Download PDF
Thromb Haemost 2017; 117(05): 829
DOI: 10.1160/TH17-03-0167
T&H Insight
Schattauer GmbH

High on treatment platelet reactivity as a risk factor for adverse left ventricular remodelling after STEMI

Gian Marco Podda
1   Unità di Medicina III, ASST Santi Paolo e Carlo, Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milano, Italy
,
Marco Cattaneo
1   Unità di Medicina III, ASST Santi Paolo e Carlo, Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milano, Italy
› Author Affiliations
Further Information

Publication History

Received: 10 March 2017

Accepted: 10 March 2017

Publication Date:
28 November 2017 (online)

    Permissions and Reprints

See also:

Novel role of platelet reactivity in adverse left ventricular remodelling after ST-segment elevation myocardial infarction: The REMODELING TrialThromb Haemost 2017; 117(05): 911-922
DOI: 10.1160/TH16-10-0744

 

Insight on: Park et al. Thromb Haemost 2017; 117: 911-922.

 

  • References

  • 1 Cattaneo M. High on-treatment platelet reactivity--definition and measurement. Thromb Haemost 2013; 109: 792-798.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Westman PC, Lipinski MJ, Luger D. et al. Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction. J Am Coll Cardiol 2016; 67: 2050-2060.
    PubMedGoogle Scholar
  • 3 Park Y, Tantry US, Koh J-S. et al. Novel role of platelet reactivity in adverse left ventricular remodelling after ST-segment elevation myocardial infarction: The REMODELING Trial. Thromb Haemost 2017; 117: 911-922.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Cattaneo M. P2Y12 receptors: structure and function. J Thromb Haemost 2015; 13 (Suppl. 01) S10-16.
    CrossrefPubMedGoogle Scholar